World's 1st Polymer Free Everolimus Eluting Stent

Summit of innovative technology, offering a unique combination of Probucol and Everolimus.
ISAR SUMMIT uses a cobalt chromium platform, while the microporous surface, shellac resin and abluminal coating distinguishes it from other drug eluting stents.

Summit Of Innovative Technology

Drug Release Kinetics

*Biomaterials 2009 Feb; 30(4):632-7

Probucol: A Safer Alternative

*Data on file (IMTR Report 20210931)

Summit of Delivery Systems

Low Crossing Profile (0.89mm)

for enhanced deliverability.

Abluminal Coating

leading to faster endothelialisation.

Optimal Strut Thickness (68 µm)

for optimal radial strength.

Shellac Resin (Wax Free)

Acts like a smooth coat of drug matrix to prevent stent breakup during expansion.

Primary Endpoints

Composite safety endpoint of Target Lesion Failure (TLF) rate at 12 months post-index procedure

Secondary Endpoints

Clinical endpoints measured at 30, 180 days and 1 year post index procedure

Type and press enter to search